PHILADELPHIA--(BUSINESS WIRE)--Tourmaline Capital Partners (Tourmaline), a next-generation real estate firm focused on Class-A office investments throughout the United States, has announced its entry ...

Product prices include realized gains and losses on risk management activities and financial instrument contracts. This news release contains forward-looking information and statements (collectively, ...

Tourmaline Oil delivered record production, reserves, and lower costs in Q4 2025, reinforcing its position as Canada’s leading gas producer. TRMLF’s 2P reserves now exceed 6 billion boe with a 26-year ...

The market shrugged off Tourmaline Oil Corp.'s (TSE:TOU) solid earnings report. Our analysis showed that there are some concerning factors in the earnings that investors may be cautious of. AI is ...

Tourmaline Bio, Inc. announced its first quarter 2025 financial results, highlighting its ongoing Phase 2 TRANQUILITY trial which is set to reveal topline data in the second quarter of 2025. The trial ...

A lackluster earnings announcement from Tourmaline Oil Corp. ( TSE:TOU ) last week didn't sink the stock price.

BERLIN (Reuters) - Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on ...

Novartis NOVN0.18%increase; green up pointing triangle agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted ...